封面
市場調查報告書
商品編碼
1529758

電泳市場規模、佔有率、趨勢分析報告:2024-2030 年按產品、應用、最終用途、地區和細分市場進行的預測

Electrophoresis Market Size, Share & Trends Analysis Report By Product (Electrophoresis Reagents, Systems), By Application, By End-use (Academic and Research Institutes), By Region, And Segment Forecasts, 2024 - 2030

出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

電泳市場規模及趨勢

2023年全球電泳市場規模預估為31.7646億美元,預估2024年至2030年複合年成長率為5.3%。推動這一成長的關鍵因素包括心血管疾病和癌症等慢性病的盛行率不斷上升、對個人化藥物的需求不斷成長以及由於技術進步而加強的產學合作。此外,基因組學和蛋白​​質組學研究資金的增加以及臨床實驗室數量的增加可能會在預測期內推動市場。

癌症和感染疾病患者病率的上升增加了早期診斷的需求。 2024年2月,世界衛生組織估計,到2050年,全球癌症病例數將達到3,500萬人。這種日益普遍的現象正在推動對先進診斷和治療技術(包括電泳試劑和系統)的需求。電泳是癌症研究、診斷和監測中使用的重要技術,可以分離和分析蛋白質、核酸和其他生物分子。肺癌是全球癌症死亡的第一大原因,2022年將導致180萬人死亡,佔所有癌症死亡的18.7%。

學術機構和產業之間的合作正在推動電泳技術的創新,特別是在基因組學、蛋白質組學和個人化醫療領域。這些合作夥伴關係利用先進的電泳技術來識別生物標記,在分子層面上研究疾病機制,並開發針對個體遺傳特徵的標靶治療。此外,高性能電泳系統在臨床診斷和藥物研究中的整合不斷增加,加速了更精確、更有效率的分析方法的開發。 2022 年 5 月在 PLOS ONE 雜誌上發表的一項最新研究強調了使用凝膠電泳來識別與肺癌 Ta 亞型的腫瘤進展和分子特異性相關的關鍵蛋白質。這項技術使研究人員能夠識別癌細胞中的蛋白質,這有助於準確診斷,並有助於開發針對特定肺癌部位的標靶治療。

電泳套件和試劑的技術進步提高了電泳技術在各種科學和臨床應用中的效率、準確性和多功能性,徹底改變了電泳技術。其中一項關鍵進展是用於凝膠電泳的新型凝膠基質的配製,可提高 DNA、RNA 和蛋白質等生物分子的解析度並加快分離速度。例如,2022 年 9 月,為研究人員提供科學設備的領先供應商 miniPCR bio 宣布推出 BanditTM STEM 電泳,這是一種創新的教育工具,使學生能夠以實惠的價格組裝和操作功能齊全的凝膠電泳套件。該套件旨在促進 STEM 教育領域的體驗式學習。

該市場的進一步特點是自動化系統和機器人技術在電泳平台中的整合,從而簡化了實驗室工作流程。自動化電泳設備利用基於微流體晶片的技術,將蛋白質和核酸等生物分子的螢光檢測、電泳分離和資料分析無縫整合到一個平台中。例如,Experion 分析晶片採用 Caliper Life Sciences 開發的 LabChip 技術。此微流體晶片充當強大的小型實驗室,封裝了多個大型桌上型分析儀的功能。每個晶片都具有連接樣品孔、分離通道和緩衝孔的微通道網路。

此外,自動化的凝膠負載、樣品處理和資料分析過程可最大限度地減少人為錯誤並提高重現性,使電泳對研究人員和臨床醫生來說更加容易和可靠。此外,單細胞蛋白質組學和血漿生物標記發現的進步也推動了對具有更高通量和重現性的電泳技術的需求。電泳工作流程的自動化和小型化是滿足這些不斷變化的研究需求的關鍵焦點部分。

政府舉措、增加的資金以及對基因組學和蛋白​​質組學的大量投資也在推動市場成長。耶魯大學基因組學和蛋白​​質組學中心以及國家癌症研究所的臨床蛋白質組學腫瘤分析聯盟等重大舉措為推進基因組學和蛋白​​質組學研究提供了大量資金。因此,對支援這些工作的高性能電泳試劑和系統的需求不斷成長。此外,2023年10月,加拿大政府宣布將在五年內投資1,500萬美元建立泛加拿大基因組圖書館,這是該國第一個國家集中式基因組資料管理系統。該圖書館將使疾病特別是罕見疾病的更個人化的治療成為可能。旨在建立此類研究能力的舉措有望推動電泳系統和試劑的需求。

全球電泳市場報告細分

該報告預測了全球、區域和國家層面的收益成長,並對 2018 年至 2030 年各子區隔的最新行業趨勢進行了分析。在這項研究中,Grand View Research, Inc. 根據產品、應用、最終用途和地區對全球電泳市場報告進行了細分。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章電泳市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/補充市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 電泳市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章電泳市場:依產品分類的估算與趨勢分析

  • 全球電泳市場:產品儀表板
  • 全球電泳市場:產品差異分析
  • 全球電泳市場:依產品和收益
  • 電泳試劑
  • 電泳系統
  • 凝膠文件系統
  • 軟體

第5章電泳市場:按應用估算與趨勢分析

  • 2023年及2030年應用市場佔有率
  • 細分儀表板
  • 全球電泳市場按應用前景
  • 2018-2030年市場規模、預測及趨勢分析

第6章電泳市場:依最終用途分類的估計與趨勢分析

  • 2023 年及 2030 年最終用途市場佔有率
  • 細分儀表板
  • 按最終用途分類的全球電泳市場展望
  • 2018-2030年市場規模、預測及趨勢分析

第7章電泳市場:區域估計與趨勢分析

  • 2023 年及 2030 年按地區分類的市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概述
  • 2018-2030年市場規模、預測趨勢分析:
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • 2023年主要企業市場佔有率分析
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • GE Healthcare
    • QIAGEN NV
    • Lonza Group Ltd.
    • Agilent Technologies, Inc.
    • PerkinElmer, Inc.
    • Danaher Corporation
    • Harvard Bioscience, Inc.
    • Shimadzu Corporation
Product Code: GVR-4-68040-344-0

Electrophoresis Market Size & Trends

The global electrophoresis market size was estimated at USD 3,176.46 million in 2023 and is projected to grow at a CAGR of 5.3% from 2024 to 2030. This growth is attributed to the increasing prevalence of chronic diseases such as CVD and cancer, increasing industry academia collaborations coupled with the rising need for personalized medicines and technological advancements are major factors driving the market. Furthermore, increasing funding for genomics and proteomics research and rising number of clinical laboratories are likely to drive the market over the forecast period.

The rising prevalence of cancer and infectious diseases is driving the need for early diagnosis. In February 2024, WHO estimated the global cancer burden to reach an estimated number of 35 million new cases by 2050, a 77 % rise to that of 20 million in 2022. This increasing prevalence is driving demand for advanced diagnostic and treatment technologies, including electrophoresis reagents and systems. Electrophoresis is a crucial technique used in cancer research, diagnosis, and monitoring, enabling the separation and analysis of proteins, nucleic acids, and other biomolecules. Lung cancer is the leading cause of cancer death worldwide, accounting for 1.8 million deaths 18.7% of total cancer deaths in 2022.

Collaborations between academic institutions and industry players are fostering innovation in electrophoretic techniques, particularly in the fields of genomics, proteomics, and personalized medicine. These partnerships are leveraging advanced electrophoresis technologies to identify biomarkers, study disease mechanisms at a molecular level, and develop targeted therapies tailored to individual genetic profiles. Moreover, the increasing integration of high-throughput electrophoresis systems in clinical diagnostics and pharmaceutical research is accelerating the development of more precise and efficient analytical methods. In May 2022, a recent study published in the PLOS ONE Journal highlighted the use of gel electrophoresis to identify key proteins associated with tumor progression and molecular specificity in lung cancer subtypes. This technique allowed researchers to distinguish proteins from tumor cells, which can aid in accurate diagnosis and potentially contribute to the development of targeted therapies for specific lung cancer segments.

Technological advancements in electrophoresis kits and reagents have been transformative, enhancing the efficiency, accuracy, and versatility of electrophoretic techniques across various scientific and clinical applications. One key development lies in the formulation of novel gel matrices for gel electrophoresis, which offer improved resolution and faster separation of biomolecules such as DNA, RNA, and proteins. For instance, in September 2022, miniPCR bio, a leading provider of scientific equipment for researchers, introduced the BanditTM STEM Electrophoresis Kit, an innovative educational tool that enables students to construct and operate a fully functional gel electrophoresis device at an affordable price. This kit is designed to promote hands-on learning in the field of STEM education.

The market is further characterized by the integration of automated systems and robotics in electrophoresis platforms which has streamlined laboratory workflows. Automated electrophoresis instruments leverage microfluidic chip-based technology to seamlessly incorporate fluorescence detection, electrophoretic separation, and data analysis of biomolecules like proteins and nucleic acids into a single platform. For instance, the Experion analysis chip employs LabChip technology developed by Caliper Life Sciences, Inc. This microfluidic chip serves as a powerful, miniaturized laboratory, encapsulating the capabilities of multiple larger benchtop analytical instruments. Each chip features a network of microchannels that link the sample wells to a separation channel and buffer wells.

Furthermore, automated gel loading, sample handling, and data analysis processes minimize human error and improve reproducibility, making electrophoresis more accessible and reliable for researchers and clinicians. In addition, advancements in single-cell proteomics and plasma biomarker discovery are also boosting the need for electrophoresis technologies with higher throughput and reproducibility. Automation and miniaturization of electrophoresis workflows are key focus areas to meet these evolving research requirements.

Governments' initiatives, increasing funding, and substantial investments in genomics and proteomics are also driving the market growth. Major initiatives like the Yale Center for Genomics and Proteomics and the National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium are providing significant funding to advance genomics and proteomics research. This is driving demand for high-performance electrophoresis reagents and systems to support these efforts. Furthermore, in October 2023, the Government of Canada announced an investment of USD 15 million over 5 years to create the Pan-Canadian Genome Library, the country's first national, centralized genomic data management system. The Library will allow for more personalized treatment of diseases, especially rare diseases. Such initiatives aimed at research building capabilities are poised to drive demand for electrophoresis systems and reagents.

Global Electrophoresis Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global electrophoresis market report based on product, application, end use, and region:

  • Electrophoresis Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Electrophoresis Reagents

Protein Electrophoresis Reagents

Nucleic Acid Electrophoresis Reagents

  • Electrophoresis Systems

Gel Electrophoresis Systems

Capillary Electrophoresis Systems

  • Gel Documentation Systems
  • Software
  • Electrophoresis Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Research Applications
  • Diagnostics Applications
  • Quality Control and Process Validation
  • Electrophoresis End use Outlook (Revenue, USD Million, 2018 - 2030)
  • Academic and Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Hospital & Diagnostic Centers
  • Other End use
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

UK

Germany

France

Italy

Spain

Sweden

Denmark

Norway

  • Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

  • Latin America

Brazil

Argentina

  • Middle East and Africa

Saudi Arabia

South Africa

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End Use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Electrophoresis Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of chronic diseases
      • 3.2.1.2. Increasing industry academia collaborations
      • 3.2.1.3. Rising need for personalized medicines
      • 3.2.1.4. Technological advancements
      • 3.2.1.5. Increasing funding for genomics and proteomics research
      • 3.2.1.6. Rising number of clinical laboratories
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Untrained personnel
      • 3.2.2.2. Stringent regulations
  • 3.3. Electrophoresis Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Electrophoresis Market: Product Estimates & Trend Analysis

  • 4.1. Global Electrophoresis Market: Product Dashboard
  • 4.2. Global Electrophoresis Market: Product Movement Analysis
  • 4.3. Global Electrophoresis Market by Product, Revenue
  • 4.4. Electrophoresis Reagents
    • 4.4.1. Electrophoresis reagents market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Protein Electrophoresis Reagents
      • 4.4.2.1. Protein electrophoresis reagents market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Nucleic Acid Electrophoresis Reagents
      • 4.4.3.1. Nucleic acid electrophoresis reagents market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Electrophoresis Systems
    • 4.5.1. Electrophoresis systems market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Gel Electrophoresis Systems
      • 4.5.2.1. Gel electrophoresis systems market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Capillary Electrophoresis Systems
      • 4.5.3.1. Capillary electrophoresis systems market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Gel Documentation Systems
    • 4.6.1. Gel documentation systems market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Software
    • 4.7.1. Software market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Electrophoresis Market: Application Estimates & Trend Analysis

  • 5.1. Application Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Electrophoresis Market by Application Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Research Applications
      • 5.4.1.1. Research applications market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Diagnostics Applications
      • 5.4.2.1. Diagnostics applications market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Quality Control and Process Validation
      • 5.4.3.1. Quality control and process validation market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Electrophoresis Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Electrophoresis Market by End Use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Academic and Research Institutes
      • 6.4.1.1. Academic and research institutes market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Pharmaceutical and Biotechnology Companies
      • 6.4.2.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Hospital and Diagnostic Centers
      • 6.4.3.1. Hospital and diagnostic centers market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Electrophoresis Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ Reimbursement
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ Reimbursement
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ Reimbursement
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ Reimbursement
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/ Reimbursement
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ Reimbursement
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ Reimbursement
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ Reimbursement
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.1. Regulatory framework/ Reimbursement
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.1. Regulatory framework/ Reimbursement
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.1. Regulatory framework/ Reimbursement
      • 7.7.6.2. Competitive scenario
      • 7.7.6.3. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ Reimbursement
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/ Reimbursement
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/ Reimbursement
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/ Reimbursement
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Bio-Rad Laboratories, Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Others benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Thermo Fisher Scientific Inc.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Others benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Merck KGaA
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Others benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. GE Healthcare
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Others benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. QIAGEN N.V.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Others benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Lonza Group Ltd.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Others benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Agilent Technologies, Inc.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Others benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. PerkinElmer, Inc.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Others benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Danaher Corporation
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Others benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Harvard Bioscience, Inc.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Others benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Shimadzu Corporation
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Others benchmarking
      • 8.3.14.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America electrophoresis market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 6 U.S. electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Mexico electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 13 Mexico electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 14 Mexico electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe electrophoresis market, by region, 2018 - 2030 (USD Million)
  • Table 16 Europe electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 17 Europe electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 18 Europe electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Germany electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 20 Germany electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 21 Germany electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 22 UK electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 23 UK electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 24 UK electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 25 France electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 26 France electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 27 France electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Italy electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 29 Italy electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 30 Italy electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Spain electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 32 Spain electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 33 Spain electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Denmark electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 35 Denmark electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 36 Denmark electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Sweden electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 38 Sweden electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 39 Sweden electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Norway electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 41 Norway electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 42 Norway electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific electrophoresis market, by region, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 47 China electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 48 China electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 49 China electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Japan electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 51 Japan electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 52 Japan electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 53 India electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 54 India electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 55 India electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 56 South Korea electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 57 South Korea electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 58 South Korea electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Australia electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 60 Australia electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 61 Australia electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Thailand electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 63 Thailand electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 64 Thailand electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Latin America electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 66 Latin America electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 67 Latin America electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Brazil electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 69 Brazil electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 70 Brazil electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 71 Argentina electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 72 Argentina electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 73 Argentina electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 74 MEA electrophoresis market, by region, 2018 - 2030 (USD Million)
  • Table 75 MEA electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 76 MEA electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 77 MEA electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 78 South Africa electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 79 South Africa electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 80 South Africa electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 84 UAE electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 85 UAE electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 86 UAE electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 87 Kuwait electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 88 Kuwait electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 89 Kuwait electrophoresis market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Electrophoresis market: market outlook
  • Fig. 14 Electrophoresis competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Electrophoresis market driver impact
  • Fig. 20 Electrophoresis market restraint impact
  • Fig. 21 Electrophoresis market strategic initiatives analysis
  • Fig. 22 Electrophoresis market: Product movement analysis
  • Fig. 23 Electrophoresis market: Product outlook and key takeaways
  • Fig. 24 Electrophoresis reagents market estimates and forecast, 2018 - 2030
  • Fig. 25 Protein electrophoresis reagents market estimates and forecast, 2018 - 2030
  • Fig. 26 Nucleic acid electrophoresis reagents market estimates and forecast, 2018 - 2030
  • Fig. 27 Electrophoresis systems market estimates and forecast, 2018 - 2030
  • Fig. 28 Gel electrophoresis systems market estimates and forecast, 2018 - 2030
  • Fig. 29 Capillary electrophoresis systems market estimates and forecast, 2018 - 2030
  • Fig. 30 Gel documentation systems market estimates and forecast, 2018 - 2030
  • Fig. 31 Software market estimates and forecast, 2018 - 2030
  • Fig. 32 Electrophoresis market: Application movement analysis
  • Fig. 33 Electrophoresis market: Application outlook and key takeaways
  • Fig. 34 Research applications market estimates and forecast, 2018 - 2030
  • Fig. 35 Diagnostics applications market estimates and forecast, 2018 - 2030
  • Fig. 36 Quality control and process validation market estimates and forecast, 2018 - 2030
  • Fig. 37 Electrophoresis market: End use movement analysis
  • Fig. 38 Electrophoresis market: End use outlook and key takeaways
  • Fig. 39 Academic and research institutes market estimates and forecasts, 2018 - 2030
  • Fig. 40 Pharmaceutical & biotechnology companies market estimates and forecasts,2018 - 2030
  • Fig. 41 Hospital and diagnostic centers market estimates and forecasts, 2018 - 2030
  • Fig. 42 Other end use market estimates and forecasts, 2018 - 2030
  • Fig. 43 Global electrophoresis market: Regional movement analysis
  • Fig. 44 Global electrophoresis market: Regional outlook and key takeaways
  • Fig. 45 Global electrophoresis market share and leading players
  • Fig. 46 North America market share and leading players
  • Fig. 47 Europe market share and leading players
  • Fig. 48 Asia Pacific market share and leading players
  • Fig. 49 Latin America market share and leading players
  • Fig. 50 Middle East & Africa market share and leading players
  • Fig. 51 North America, by country
  • Fig. 52 North America
  • Fig. 53 North America market estimates and forecasts, 2018 - 2030
  • Fig. 54 U.S. key country dynamics
  • Fig. 55 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 56 Canada key country dynamics
  • Fig. 57 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 58 Mexico key country dynamics
  • Fig. 59 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 60 Europe
  • Fig. 61 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 62 UK key country dynamics
  • Fig. 63 UK market estimates and forecasts, 2018 - 2030
  • Fig. 64 Germany key country dynamics
  • Fig. 65 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 66 France key country dynamics
  • Fig. 67 France market estimates and forecasts, 2018 - 2030
  • Fig. 68 Italy key country dynamics
  • Fig. 69 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 70 Spain key country dynamics
  • Fig. 71 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 72 Denmark key country dynamics
  • Fig. 73 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 74 Sweden key country dynamics
  • Fig. 75 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 76 Norway key country dynamics
  • Fig. 77 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 78 Asia Pacific
  • Fig. 79 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 80 China key country dynamics
  • Fig. 81 China market estimates and forecasts, 2018 - 2030
  • Fig. 82 Japan key country dynamics
  • Fig. 83 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 84 India key country dynamics
  • Fig. 85 India market estimates and forecasts, 2018 - 2030
  • Fig. 86 Thailand key country dynamics
  • Fig. 87 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 88 South Korea key country dynamics
  • Fig. 89 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 90 Australia key country dynamics
  • Fig. 91 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 92 Latin America
  • Fig. 93 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 94 Brazil key country dynamics
  • Fig. 95 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 96 Argentina key country dynamics
  • Fig. 97 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 98 Middle East and Africa
  • Fig. 99 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 100 South Africa key country dynamics
  • Fig. 101 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 102 Saudi Arabia key country dynamics
  • Fig. 103 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 104 UAE key country dynamics
  • Fig. 105 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 106 Kuwait key country dynamics
  • Fig. 107 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 108 Market share of key market players- Electrophoresis market